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We evaluated macular function before and after panretinal photocoagulation (PRP) in 
diabetic retinopathy using a multifocal electroretinogram (mfERG) and optical coherence 
tomogram (OCT).  In mfERGs, the 1st positive wave (P1) minus the 1st negative wave 
(N1) amplitude (P1 – N1 amplitude), the P1 peak latency and the response density were 
measured in 7, 19, 37 and 103 hexagonal areas or elements (Areas 1, 2, 3 and 4) within 
a central radius of 5, 7, 10 and 20 degrees, respectively.  The mean retinal thickness was 
estimated from 9 calculation points at the foveal region within 5 degrees; the central and 
each of the other 4 points at a distance of 250 µm and 500 µm from the central portion 
on horizontal and vertical sections on OCT.  The P1 peak latencies from the 4 areas were 
remarkably prolonged in 14 eyes of 9 patients with preproliferative or early proliferative 
diabetic retinopathy showing no clinically signiﬁcant macular edema before PRP as com-
pared with those in 15 normal control eyes, without a tendency of recovery throughout the 
course after PRP except for area 1.  The P1-N1 amplitudes and the mean response density 
levels from the 4 areas were remarkably decreased in the diabetic eyes before PRP as com-
pared with those in the control eyes, followed by a maximum decrease in both parameters 
at 3 months after PRP.  However, remarkable recoveries were detected in both decreased 
parameters from the 4 areas at 6 months after PRP.  The mean foveal retinal thickness 
on OCT was remarkably increased in the diabetic eyes before PRP as compared with the 
thickness in 16 normal control eyes.  Most remarkably, a transient increase in thickness 
was detected in diabetic eyes 1 month after PRP, followed by a tendency of recovery 3 to 6 
months after PRP.  These results indicate that mfERG and OCT examinations are useful 
in the assessment of macular function before and after PRP in diabetic retinopathy, espe-
cially within 5 degrees of the central portion, and that the effects of PRP on macular func-
tion in this entity seem to be reversible at the foveal region, although we need to do further 
investigation in relation to the outcome of visual acuity.
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Panretinal photocoagulation (PRP) is a beneficial 
procedure for the treatment of preproliferative or 
early proliferative diabetic retinopathy (Diabetic 
Retinopathy Study Research Group, 1981; Early 
Treatment Diabetic Retinopathy Study Research 
Group, 1991), even though vitrectomy has been 
performed in many patients with severe and com-
plicated diabetic lesions (Lewis et al., 1992; Massin 
et al., 2003).  On that occasion, the assessment of 
macular function is very important for predicting 
the patientsʼ quality of vision after PRP.  Several re-
ports showed various changes in retinal sensitivity 
after PRP in this entity, using mostly the Goldmann 
kinetic perimeter (Frank, 1975), the computed 
static perimeter (Chee and Flanagan, 1993; Yoon et 
al., 1996) and the electroretinogram (ERG) (Frank, 
1975; Bresnick and Palta, 1987).
        Using an optical coherence tomogram (OCT), 
Hee and his co-workers (1995, 1998) and Kang and 
others (2004) quantified foveal retinal thickness 
correlated with visual acuity in patients with clini-
cally significant diabetic macular edema.  Recently, 
Palmowski and others (1997) and Fortune and oth-
ers (1999) revealed local retinal dysfunction in the 
macular area in diabetic patients, with and without 
retinopathy, using a multifocal electroretinogram 
(mfERG) (Sutter and Tran, 1992).  In general, 
morphological changes in the retina are assessed 
by OCT examination because optical coherence 
tomography offers high-resolution, cross-sectional 
images of the retina and quantitative measurement 
of retinal thickness (Hee et al., 1995, 1998; Kang et 
al., 2004), while topical functional changes in the 
retinal layer are assessed with mfERG examina-
tion, using a multifocal technique (Sutter and Tran, 
1992; Palmowski et al., 1997; Fortune et al., 1999).  
        These tests allow a relatively fast, objective 
evaluation of retinal function in their images and 
patterns in contrast to subjective perimetric examina-
tions such as the Goldmann kinetic perimeter (Frank, 
1975) and the computed static perimeter (Chee 
and Flanagan, 1993; Yoon et al., 1996).  However, 
little attention has been paid to the assessment of 
macular function by mfERG and OCT examina-
tions before and after PRP in diabetic patients with 
retinopathy.  We therefore evaluated macular func-
tion before and after PRP in diabetic retinopathy by 
multifocal electroretinography and optical coher-
ence tomography in this survey.
Subjects and Methods
Nine patients (14 eyes) with preproliferative or 
early proliferative diabetic retinopathy showing no 
clinically significant macular edema were referred 
to us for this study.  Their ages ranged from 51 
to 77 years averaging 61.2 ± 8.6 years (SD).  The 
mean corrected visual acuity of the 14 diabetic eyes 
before PRP was 0.87 ± 0.37 (SD), followed by 0.80 
± 0.37, 0.76 ± 0.33 and 0.84 ± 0.38 at 1, 3 and 6 
months after PRP, respectively.  They were exam-
ined using a VERIS Science System for the mfERG 
(Mayo Corp., Nagoya, Japan) and a Humphrey 
OCT scanner (Carl Zeiss Co., Ltd., Tokyo, Japan) 
before PRP and at 1, 3 and 6 months after the pro-
cedure, as described later.
        Fourteen healthy volunteers (15 normal eyes) 
aged 51.1 ± 13.1 years (SD) on the average served 
as controls for the VERIS study, and 12 healthy 
volunteers (16 normal eyes) aged 66.1 ± 12.5 years 
(SD) on an average served as controls for the OCT 
study in the present estimation.  These healthy vol-
unteers were randomly divided into either study 
group.
        The diabetic patients were randomly chosen 
for the present survey over the past 4 years (August 
1996 to September 2000) at the Department of 
Ophthalmology, Tottori University Hospital.  The 
tenets of the Declaration of Helsinki were followed. 
Upon giving informed consent, all subjects includ-
ing volunteers participated in the present study. Er-
ror of refraction did not exceed ± 3 diopters in the 
diabetics or normal controls.  Eyes with clouding 
of the media or subjected to previous surgery were 
excluded from the analysis.
Abbreviations: ERG, electroretinogram; ETDRS, Early Treatment Diabetic Retinopathy Study; mfERG, multifocal 
electroretinogram; N1, 1st negative wave; OCT, optical coherence tomogram; P1, 1st positive wave; PRP, panretinal 
photocoagulation
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mfERG areas
Area 1:
Area 2:
Area 3:
Area 4:
 5  degrees
 7  elements
 7  degrees
 19  elements
 10  degrees
 37  elements
 20  degrees
 103  elements
PRP procedure
Treatment with PRP on the diabetic patients was 
performed according to the Early Treatment Dia-
betic Retinopathy Study (ETDRS) protocol (Dia-
betic Retinopathy Study Research Group, 1981; 
Early Treatment Diabetic Retinopathy Study Re-
search Group, 1991).  All patients underwent PRP 
in 2 sittings 1 week apart, lower hemifield followed 
by upper hemifield.  Photocoagulation covered the 
entire mid periphery beyond the equator, and poste-
riorly to the area bordered by the temporal vascular 
arcades, nasal disc border and 2-disc diameter tem-
poral to the fovea.  All eyes were treated with either 
a green argon laser (Coherent Inc., Palo Alto, CA) 
or a dye laser (Biophysic Medical Ins., Clermont-
Ferrand, Cedex, France).  Approximately 1,000 
to 2,000 burns of a 200 to 500 µm spot size were 
made 1 to 2 burn spaces apart through a 3-mirror 
universal lens (Ocular Instruments Inc., Bellevne, 
WA) or a double aspheric lens Trans Equator or 
Quadr Aspheric (Volk Optical Inc., Mentor, OH).
mfERG examination
The VERIS Science System, which is a visual evok-
ed response imaging system originally developed 
by Sutter and Tran (1992), was used for the mfERG 
recording.  The mfERG stimulus matrix consisted 
of 103 concentrically scaled hexagons, which cov-
ered the fundus area within a central radius of 20 
degrees (Fig. 1).  Alternated color changes were set 
in each hexagon between black and white in binary 
m-sequences at a rate of 75 Hz.  Luminance lev-
els ranged from 5 to 200 cd/m2.  A Burian-Allen 
bipolar contact lens electrode was used for signal 
derivation.  A grounding electrode was attached to 
either earlobe, a routine procedure.  The pupil of 
one eye was fully dilated with 2.5% phenylephrine 
hydrochloride, and the other eye was occluded. 
The net recording time for each eye was 4 min. 
The entire procedure was divided into eight 30-s 
segments.  The signals were amplified using the 
VERIS Science System with bandpass filters (10–
300 Hz).  
        As demonstrated in Fig. 2, in the response 
arrays of the mfERG consisting of the mean fo-
cal flash response (Fig. 2a), the 1st positive wave 
of each mean focal flash response (P1) minus the 
1st negative wave of each response (N1) amplitude 
(P1 – N1 amplitude) in µV and the P1 peak latency 
in ms were measured as mfERG parameters in 7, 
19, 37 and 103 hexagonal areas or elements (Areas 
1, 2, 3 and 4; 4 mfERG areas) within a central ra-
dius of 5, 7, 10 and 20 degrees, respectively (Fig. 
1).  Three-dimensional topography revealed the re-
Fig. 1.  The multifocal electroretino-
gram (mfERG) stimulus matrix con-
sisting of 103 concentrically scaled 
hexagons.  The matrix was divided 
into 7, 19, 37 and 103 hexagonal areas 
or elements (Areas 1, 2, 3 and 4; 4 
mfERG areas) within a central radius 
of 5, 7, 10 and 20 degrees, respec-
tively.
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sponse density in each hexagonal area in amplitude 
per retinal area (nV per degree squared: nV/deg2) in 
the topograph (Fig. 2b).  The response density was 
also adopted as one of the mfERG parameters (Fig. 
2) and measured in the 4 mfERG areas in this sur-
vey.  The recording procedure was repeated at the 
time when spurious potentials from eye blinks on 
ocular movement were involved.
OCT examination
Optical coherence tomography was used for mea-
surement of retinal thickness in µm.  The optical 
coherence tomography system was interfaced using 
fi ber optics to a conventional slit-lamp biomicro-
scope and a fi xed +78-diopter condensing lens for 
retinal examination.  An infrared-sensitive video 
camera provided a view of the scanning probe 
beam on the fundus so that the location of each 
scan on the retina could be monitored.  A comput-
er-controlled light placed in the visual fi eld fi xated 
the eye being scanned.  Fine positioning for the 
OCT examination on the retina was accomplished 
by keyboard control for scan length, angular orien-
tation and position relative to the patient sʼ fi xation 
point.
        The mean retinal thickness was estimated 
from 9 calculation points at the foveal region within 
5 degrees in the thickness estimation in the aver-
aged OCT scans by our computer program, that 
is, the central and each of the other 4 points at a 
distance of 250 µm and 500 µm from the central 
portion on horizontal and vertical sections in linear 
pattern on OCT (Fig. 3).  Retinal thickness was 
mea sured at the distance between the strongest 2 
edges in each tomogram, which most likely corre-
Fig. 2.  Multifocal electro reti nogram (mfERG) parameters calculated in this survey.  The P1 and N1 indicate the 1st 
posi tive and negative wave of each mean focal fl ash response in the response arrays of the mfERG (a), respectively. 
The 3-dimensional topograph (b) represents the response density in each hexagonal area (amplitude per retinal area: 
nV/deg2).  The mfERG parameters, that is, the P1 – N1 amplitude, the P1 peak latency and the response density are 
demonstrated as 1, 2 and 3 in this fi gure, respectively.
1: P1 – N1 amplitude
(nV)
2: P1 peak latency
(ms)
3: Response density
(nV/deg2)
3
N1
P1
1
2
a b
mfERG parameters
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Fig. 3.  Calculation points on optical coherence tomogram (OCT).  The mean retinal thickness was estimated from 
9 calculation points at the foveal region within 5 degrees; the central and each of the other 4 points at a distance of 
250 µm and 500 µm from the central portion on the horizontal and vertical sections on OCT.  Horizontal and vertical 
cross-sectional tomographic images are inserted in this figure. 
sponded to the vitreoretinal interface and the reti-
nal pigment epithelium, respectively.
        We not only used the retinal thickness pro-
gram, but also hard copies of each OCT image for 
checking errors, because the layer of cystoid macu-
lar edema was sometimes detected as the edge of 
the retinal pigment epithelium and the detached 
vitreoretinal membrane was also detected as the 
edge of the vitreoretinal interface.  In OCT mea-
surement, the subject sʼ pupil was fully dilated with 
2.5% phenylephrine hydrochloride.
Statistical analysis
All values obtained in the mfERG and OCT exami-
nations were expressed as mean ± SEM.  Statistical 
analysis was performed with Mann-Whitney sʼ U 
test.  A P value of < 0.05 was considered statisti-
cally significant.
 
Results
 
The P1 peak latencies obtained from the 4 mfERG 
areas were significantly prolonged in the 14 eyes of 
the 9 patients with preproliferative or early prolifer-
ative diabetic retinopathy who showed no clinically 
significant macular edema before PRP as compared 
with those in 15 normal control eyes of 14 healthy 
volunteers at level of 1%, with no tendency for re-
covery throughout the course after PRP except for 
area 1 (within a central radius of 5 degrees) (Fig. 4).
        The P1 – N1 amplitudes obtained from the 4 
mfERG areas were significantly decreased in the 14 
diabetic eyes before PRP as compared with those in 
the 15 control eyes at the 1% or 5% level, followed 
by a maximum decrease in the parameter 3 months 
after PRP.  However, significant recoveries were 
detected in the decreased P1 – N1 amplitudes from 
the 4 areas at 6 months after PRP at the 1% or 5% 
level (Fig. 5).
        The mean response density levels obtained 
from the 4 mfERG areas also showed almost the 
OCT calculation points
500 µm
250 µm 
Foveola
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Fig. 7.  Changes in the mean foveal retinal thickness 
within 5 degrees on OCT in 14 diabetic eyes before and 
after PRP.  All values were expressed as mean ± SEM. 
Each bar indicates SEM.  * indicates P < 0.05 by Mann-
Whitney sʼ U test.  PRP, panretinal photocoagulation; 
mo, month(s).  Control:  16 normal control eyes of 12 
healthy volunteers.
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Fig. 4.  Changes in the P1 peak latencies of the mfERG 
obtained from 4 mfERG areas in 14 diabetic eyes before 
and after PRP.  The diabetic eyes were derived from 
9 patients with preproliferative or early proliferative 
diabetic retinopathy showing no clinically significant 
macular edema in this series.  All values were expressed 
as mean ± SEM.  Each bar indicates SEM.  ** indicates 
P < 0.01 by Mann-Whitney sʼ U test.  PRP, panretinal 
photocoagulation; mo, month(s).  Control: 15 normal 
control eyes of 14 healthy volunteers.
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Fig. 5.  Changes in the P1 – N1 amplitudes of the 
mfERG obtained from 4 mfERG areas in 14 diabetic 
eyes before and after PRP.  All values were expressed as 
mean ± SEM.  Each bar indicates SEM.  * indicates P 
< 0.05, and ** indicates P < 0.01 by Mann-Whitney sʼ U 
test.  PRP, panretinal photocoagulation; mo, month(s). 
Control:  15 normal control eyes of 14 healthy volun-
teers.
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Fig.  6.  Changes in the mean response density levels of 
the mfERG obtained from 4 mfERG areas in 14 diabetic 
eyes before and after PRP.  All values were expressed as 
mean ± SEM.  Each bar indicates SEM.  * indicates P 
< 0.05, and ** indicates P < 0.01 by Mann-Whitney sʼ U 
test.  PRP, panretinal photocoagulation; mo, month(s). 
Control:  15 normal control eyes of 14 healthy volunteers.
Symbols used in Figs. 4 to 6:
Area 1:    5 degrees 
Area 2:    7 degrees 
Area 3:  10 degrees 
Area 4:  20 degrees 
**P < 0.01   *P < 0.05
**P < 0.01
  *P < 0.05  *P < 0.05
**P < 0.01
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Fig. 8.  Summarized data obtained in the present study before and after PRP in 14 diabetic eyes.  In the mfERG para-
meters, the P1 peak latency from the area 1 (within a central radius of 5 degrees), the P1 – N1 amplitudes and the 
mean response density levels from the 4 mfERG areas are presented at 1, 3 and 6 months after PRP following each 
data before PRP in addition to the mean foveal retinal thickness within 5 degrees on OCT.  The mean corrected vi-
sual acuity in the 14 diabetic eyes is also presented throughout the course.  PRP, panretinal photocoagulation; mo, 
months(s).
same tendency as in the P1 – N1 amplitudes, as 
shown in Fig. 6.  That is, the mean response density 
levels from the 4 areas were remarkably decreased 
in the 14 diabetic eyes before PRP as compared 
with those in the 15 control eyes at the 1% or 5% 
level, followed by a maximum decrease in the pa-
rameter at 3 months after PRP.  However, remark-
able recoveries were detected in the mean response 
density levels from the 4 areas at 6 months after 
PRP at the 1% or 5% level.
        The mean foveal retinal thickness within 5 
degrees on OCT was significantly increased in the 
14 diabetic eyes before PRP as compared with the 
thickness in the 16 control eyes of the 12 healthy 
volunteers at the 5% level.  Most remarkably, a 
transient increase in the thickness was detected in 
the diabetic eyes at 1 month after PRP, followed by 
a tendency for recovery at 3 to 6 months after PRP 
(Fig. 7).
Discussion
As summarized in Fig. 8, in the mfERG param-
eters, the P1 peak latency from the area 1 (within 
a central radius of 5 degrees) was markedly pro-
longed in the 14 diabetic eyes before PRP as com-
pared with that in the 15 control eyes, but a tenden-
cy for recovery was detected throughout the course 
after the procedure (Fig. 4). 
        The P1 – N1 amplitudes and the mean re-
sponse density levels from the 4 mfERG areas were 
remarkably decreased in the diabetic eyes before 
PRP as compared with those in the control eyes, 
followed by a maximum decrease in both param-
eters at 3 months after PRP.  However, remarkable 
recoveries were detected in both decreased param-
eters from the 4 areas at 6 months after PRP (Figs. 5, 
6 and 8).  
        The mean foveal retinal thickness within 5 
degrees on OCT was remarkably increased in the 
diabetic eyes before PRP as compared with the 
Foveal retinal thickness
(within 5 degrees)
on OCT
P1 – N1 amplitude
(4 mfERG areas)
Response density
P1 peak latency
(Area 1: 5 degrees)
Corrected visual acuity
(mean � SD)
(4 mfERG areas)
0.87�0.37 0.80�0.37 0.76�0.33 0.84�0.38
 Before PRP After PRP
mfERG parameters  1 mo 3 mo 6 mo
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thickness in the 16 control eyes.  Most remarkably, 
a transient increase in the thickness was detected 
in the diabetic eyes at 1 month after PRP, followed 
by a tendency of recovery at 3 to 6 months after the 
procedure (Figs. 7 and 8).
        This time, statistical analysis was not under-
taken on the correlation between the corrected vi-
sual acuity and each data from the mfERG or OCT 
examinations before and after PRP in each diabetic 
eye due to the relatively small number of samples. 
However, as demonstrated in Fig. 8, it is of note 
that the mean corrected visual acuity before PRP 
in the 14 diabetic eyes showed a gradual decrease 
at 1 month, followed by a maximum decrease at 
3 months and a tendency of gradual recovery at 6 
months after the procedure in each mean corrected 
visual acuity in those eyes, as in the changes in the 
P1 – N1 amplitudes and the mean response density 
levels of the mfERG obtained from the 4 mfERG 
areas in the 14 diabetic eyes before and after PRP.
        The OCT findings showed no coincidental 
changes between mean foveal retinal thickness and 
mean corrected visual acuity in the 14 diabetic eyes 
throughout the course after PRP.  However, ten-
dency of recovery in mean foveal retinal thickness 
at 3 to 6 months after PRP may reflect a reversible 
foveal function resulting in a gradual recovery of 
the mean corrected visual acuity at 6 months after 
the procedure in diabetic eyes (Fig. 8), although 
we need to do further investigation on this point in 
more subject patients.
        The mfERG derived from the fundus area, 
especially within 5 degrees of the central portion 
(Area 1) is supposed to reflect a cone-dominated re-
sponse, which originates predominantly in the outer 
70% of the retina, as in the full-field flash ERG 
(Hood et al., 1997; Palmowski et al., 1997; Fortune 
et al., 1999).
        Optical coherence tomography provides non-
invasively a cross- sectional tomographic image of 
the retina as described above and is more sensitive 
to small changes in retinal thickness than slit-lamp 
biomicroscopy (Hee et al., 1995, 1998; Kang et al., 
2004).
        Thus, the results obtained in the present sur-
vey indicate that the mfERG and OCT examina-
tions are useful for assessment of macular function 
before and after PRP in diabetic retinopathy, espe-
cially within 5 degrees of central portion, and that 
the effects of PRP on the macular function in this 
entity seem to be reversible at the foveal region, al-
though we need a further investigation in relation to 
the outcome of visual acuity.
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